What is the clinical evidence from this study?

Study design: Review. Population: Anticoagulant-related nephropathy. Intervention: Anticoagulant therapy.

What does this research mean for the field?

Anticoagulant-related nephropathy is an under-recognized condition characterized by acute kidney injury secondary to anticoagulant therapy, for which a synthesized peri-biopsy and therapeutic management strategy can provide a structured framework to improve patient outcomes. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To summarize current knowledge on the risk factors, pathogenesis, and clinical features of anticoagulant-related nephropathy (ARN) and establish structured guidance for peri-biopsy and therapeutic anticoagulation.

September 14, 2026Clinical Kidney JournalOpen Access

Review proposes a diagnostic flowchart and management strategy for anticoagulant-related nephropathy.

View Full Paper

Ask AI

Bookmark

Why the study?

Anticoagulant-related nephropathy (ARN) is considered rare but may be underdiagnosed due to limited awareness and lacks comprehensive management strategies.

Population

Patients with or at risk for anticoagulant-related nephropathy

Comparison

Peri-biopsy and therapeutic anticoagulation management strategies

Design

Review of published case reports and literature

Key result

This review proposes a synthesized strategy and diagnostic flowchart for the management of anticoagulant-related nephropathy during peri-biopsy and treatment phases based on case-level evidence.

Authors

YCYiwen Chen HYHao Yan JWJingJing Wu

Discussion

Member takes

Overview

May guide ARN management peri-biopsy; hypothesis-generating from case reports and requires prospective validation.

Key Points

To summarize current knowledge on the risk factors, pathogenesis, and clinical features of anticoagulant-related nephropathy (ARN) and establish structured guidance for peri-biopsy and therapeutic anticoagulation.
Reviewed published global literature, including over 100 documented clinical case reports, on the clinical presentation and renal pathology of ARN.
Synthesized observational evidence on non-vitamin K oral anticoagulants alongside standard perioperative antithrombotic principles to construct a diagnostic flowchart and peri-biopsy strategy.
Identified acute kidney injury with extensive tubular red blood cell casts and acute tubular necrosis in the absence of active glomerulonephritis as the defining pathological hallmarks of ARN.
Proposed a structured decision-making framework and diagnostic flowchart to safely navigate the trade-off between biopsy-associated bleeding and thromboembolic risk during anticoagulant interruption and resumption.

Structured PICO

Population

Patients with or at risk for anticoagulant-related nephropathy (ARN)

Exposure

Peri-biopsy and therapeutic anticoagulation management strategies

This review synthesizes current knowledge on anticoagulant-related nephropathy and proposes a structured management strategy for peri-biopsy and therapeutic anticoagulation to improve patient outcomes.

Limitations

Reliance on case-level evidence
current reliance on case-level evidence

Cite This Study

Chen et al. (2026) conducted a review in Anticoagulant-related nephropathy. Anticoagulant therapy was evaluated. This review proposes a synthesized strategy and diagnostic flowchart for the management of anticoagulant-related nephropathy during peri-biopsy and treatment phases based on case-level evidence.

synapsesocial.com/papers/6aa7afef79e9260bc85aacd1 https://doi.org/10.1093/ckj/sfag325

View Full Paper

Ask AI

Bookmark

September 14, 2026Clinical Kidney JournalOpen Access

Review proposes a diagnostic flowchart and management strategy for anticoagulant-related nephropathy.

View Full Paper

Ask AI

Bookmark

Why the study?

Anticoagulant-related nephropathy (ARN) is considered rare but may be underdiagnosed due to limited awareness and lacks comprehensive management strategies.

Population

Patients with or at risk for anticoagulant-related nephropathy

Comparison

Peri-biopsy and therapeutic anticoagulation management strategies

Design

Review of published case reports and literature

Key result

This review proposes a synthesized strategy and diagnostic flowchart for the management of anticoagulant-related nephropathy during peri-biopsy and treatment phases based on case-level evidence.

Authors

YCYiwen Chen HYHao Yan JWJingJing Wu

Discussion

Member takes

Overview

May guide ARN management peri-biopsy; hypothesis-generating from case reports and requires prospective validation.

Key Points

To summarize current knowledge on the risk factors, pathogenesis, and clinical features of anticoagulant-related nephropathy (ARN) and establish structured guidance for peri-biopsy and therapeutic anticoagulation.
Reviewed published global literature, including over 100 documented clinical case reports, on the clinical presentation and renal pathology of ARN.
Synthesized observational evidence on non-vitamin K oral anticoagulants alongside standard perioperative antithrombotic principles to construct a diagnostic flowchart and peri-biopsy strategy.
Identified acute kidney injury with extensive tubular red blood cell casts and acute tubular necrosis in the absence of active glomerulonephritis as the defining pathological hallmarks of ARN.
Proposed a structured decision-making framework and diagnostic flowchart to safely navigate the trade-off between biopsy-associated bleeding and thromboembolic risk during anticoagulant interruption and resumption.

Structured PICO

Population

Patients with or at risk for anticoagulant-related nephropathy (ARN)

Exposure

Peri-biopsy and therapeutic anticoagulation management strategies

Limitations

Reliance on case-level evidence
current reliance on case-level evidence

Cite This Study

synapsesocial.com/papers/6aa7afef79e9260bc85aacd1 https://doi.org/10.1093/ckj/sfag325

View Full Paper

Ask AI

Bookmark